Faculty Opinions recommendation of Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention.

2008 ◽  
Author(s):  
Yukio Hayashi
Keyword(s):  
Percutaneous Coronary Intervention ◽  
Coronary Intervention ◽  
Cardiac Risk ◽  
Bare Metal Stent ◽  
Bare Metal ◽  
Metal Stent ◽  
Percutaneous Coronary

Use of Prasugrel in a Patient with Clopidogrel Hypersensitivity

2011 ◽  
Vol 45 (10) ◽  
pp. 1307-1307 ◽  
Author(s):  
Sarah R Peppard ◽  
Bethanne M Held-Godgluck ◽  
Richard Beddingfield
Keyword(s):  
Percutaneous Coronary Intervention ◽  
Stent Placement ◽  
Coronary Intervention ◽  
Bare Metal Stent ◽  
Coronary Stent ◽  
Bare Metal ◽  
Metal Stent ◽  
Therapeutic Alternative ◽  
Percutaneous Coronary ◽  
Hands And Feet

Objective: To report a case of successful use of prasugrel following percutaneous coronary intervention with placement of a bare metal stent in a patient with a documented hypersensitivity reaction to clopidogrel. Case Summary: A 61-year-old male with a history of coronary artery disease with coronary stent placement presented with ST-elevation myocardial infarction. The patient had developed Stephens-Johnson syndrome 6 years earlier following Clopidogrel administration, characterized by erythematous plaques and subsequent desquamation of the hands and feet; Clopidogrel was discontinued and he was subsequently treated with ticlopidine in addition to aspirin. The third-generation thienopyridine prasugrel was initiated as a therapeutic alternative to Clopidogrel after placement of a bare metal stent; a 60-mg dose was administered after extubation, followed by 10 mg/day. No signs of allergic reaction were observed in the days, weeks, and months following administration. Discussion: Thienopyridines, specifically Clopidogrel, are the standard of care for prevention of coronary stent thrombosis; however, there are few data available on cross-hypersensitivity between these agents. One study demonstrated that 27% of patients who developed an allergic or hematologic reaction to Clopidogrel developed a similar reaction to ticlopidine. Other therapeutic options for patients with Clopidogrel hypersensitivity who are undergoing a percutaneous coronary intervention with stent placement include Clopidogrel desensitization, warfarin plus aspirin, cilostazol, ticagrelor, and ticlopidine. However, these options are limited by efficacy and/or toxicity. With its approval in 2009, prasugrel has become a potential treatment option. Conclusions: Prasugrel may be considered a therapeutic alternative in some patients allergic or intolerant to Clopidogrel, but additional data are warranted to make a strong conclusion.

Impact and Temporal Trends of Percutaneous Coronary Intervention in the Drug-Eluting Stent Versus Bare Metal Stent Eras

2005 ◽  
Vol 96 (5) ◽  
pp. 668-672 ◽  
Author(s):  
Craig A. Thompson ◽  
Aaron V. Kaplan ◽  
John E. Jayne ◽  
Bruce J. Friedman ◽  
Bruce D. Hettleman ◽  
...  
Keyword(s):  
Percutaneous Coronary Intervention ◽  
Temporal Trends ◽  
Coronary Intervention ◽  
Bare Metal Stent ◽  
Drug Eluting Stent ◽  
Bare Metal ◽  
Metal Stent ◽  
Percutaneous Coronary ◽  
Drug Eluting

scholarly journals The Relationship between VEGFA and TGFB1 Polymorphisms and Target Lesion Revascularization after Elective Percutaneous Coronary Intervention

2017 ◽  
Vol 2017 ◽  
pp. 1-8
Author(s):  
Tadeusz Osadnik ◽  
Andrzej Lekston ◽  
Kamil Bujak ◽  
Joanna Katarzyna Strzelczyk ◽  
Lech Poloński ◽  
...  
Keyword(s):  
Percutaneous Coronary Intervention ◽  
Growth Factor ◽  
Coronary Intervention ◽  
Target Lesion ◽  
Bare Metal Stent ◽  
Bare Metal ◽  
Metal Stent ◽  
Elective Percutaneous Coronary Intervention ◽  
Percutaneous Coronary ◽  
The Relationship

Background and Aim. The specific association between genetic variation and in-stent restenosis is still only partly understood. The aim of this study is to analyze the relationship between functional polymorphisms in the genes encoding vascular endothelial growth factor A (VEGF-A; rs699947) and transforming growth factor beta 1 (TGF-β1; rs1800470) and target lesion revascularization (TLR) risk. Methods. A total of 676 patients (805 lesions) with stable coronary artery disease (SCAD) who received elective percutaneous coronary intervention (PCI) with at least one bare-metal stent implantation were included. The primary study endpoint was TLR at a 4-year follow-up. Results. The TLR rate was higher in patients with the VEGFA A/A genotype (15.4%) than in patients with the VEGFA A/C (7.9%) and C/C (8.9%) genotypes (p=0.009). The VEGFA A/A genotype, after adjustment for clinical and procedural covariates, remained significantly and independently associated with the TLR (hazard ratio—2.09 [95% confidence interval 1.32–3.33, p=0.0017]). However, we found no association between TLR and the TGFB1 genotype. Conclusion. The VEGFA A/A genotype is significantly and independently associated with TLR risk in Polish SCAD patients who received elective PCI with bare-metal stent implantation.

Hybrid strategy of a bare metal stent combined with a drug-eluting stent versus exclusive drug-eluting stent implantation for multivessel percutaneous coronary intervention

2011 ◽  
Vol 6 (9) ◽  
pp. 1085-1090 ◽  
Author(s):  
Asmir Syed ◽  
Itsik Ben-Dor ◽  
Yanlin Li ◽  
Sara Collins ◽  
Rebecca Torguson ◽  
...  
Keyword(s):  
Percutaneous Coronary Intervention ◽  
Stent Implantation ◽  
Coronary Intervention ◽  
Bare Metal Stent ◽  
Drug Eluting Stent ◽  
Bare Metal ◽  
Metal Stent ◽  
Hybrid Strategy ◽  
Percutaneous Coronary ◽  
Drug Eluting

scholarly journals Percutaneous Coronary Intervention With Bare Metal Stent vs. Drug-Eluting Stent in Hemodialysis Patients

2012 ◽  
Vol 76 (7) ◽  
pp. 1609-1615 ◽  
Author(s):  
Hideki Ishii ◽  
Takanobu Toriyama ◽  
Toru Aoyama ◽  
Hiroshi Takahashi ◽  
Miho Tanaka ◽  
...  
Keyword(s):  
Percutaneous Coronary Intervention ◽  
Coronary Intervention ◽  
Bare Metal Stent ◽  
Hemodialysis Patients ◽  
Drug Eluting Stent ◽  
Bare Metal ◽  
Metal Stent ◽  
Percutaneous Coronary ◽  
Drug Eluting
Sign in / Sign up

Export Citation Format

Share Document